GSGTF
Price
$0.24
Change
-$0.08 (-25.00%)
Updated
Dec 31 closing price
Capitalization
31.39M
RPTX
Price
$1.28
Change
-$0.09 (-6.57%)
Updated
Apr 23 closing price
Capitalization
58.24M
19 days until earnings call
Ad is loading...

GSGTF vs RPTX

Header iconGSGTF vs RPTX Comparison
Open Charts GSGTF vs RPTXBanner chart's image
Gensight Biologics SA
Price$0.24
Change-$0.08 (-25.00%)
Volume$4.01K
Capitalization31.39M
Repare Therapeutics
Price$1.28
Change-$0.09 (-6.57%)
Volume$724.2K
Capitalization58.24M
GSGTF vs RPTX Comparison Chart
Loading...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GSGTF vs. RPTX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGTF is a Hold and RPTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (GSGTF: $0.24 vs. RPTX: $1.28)
Brand notoriety: GSGTF and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GSGTF: 100% vs. RPTX: 220%
Market capitalization -- GSGTF: $31.39M vs. RPTX: $58.24M
GSGTF [@Biotechnology] is valued at $31.39M. RPTX’s [@Biotechnology] market capitalization is $58.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSGTF’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • GSGTF’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than GSGTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RPTX’s TA Score shows that 4 TA indicator(s) are bullish.

  • RPTX’s TA Score: 4 bullish, 5 bearish.

Price Growth

GSGTF (@Biotechnology) experienced а 0.00% price change this week, while RPTX (@Biotechnology) price change was +11.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

RPTX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPTX($58.2M) has a higher market cap than GSGTF($31.4M). GSGTF YTD gains are higher at: 0.000 vs. RPTX (-2.290).
GSGTFRPTXGSGTF / RPTX
Capitalization31.4M58.2M54%
EBITDAN/A-90.22M-
Gain YTD0.000-2.290-
P/E RatioN/AN/A-
RevenueN/A53.5M-
Total CashN/A153M-
Total DebtN/A1.93M-
FUNDAMENTALS RATINGS
GSGTF: Fundamental Ratings
GSGTF
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RPTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GOOY11.690.23
+2.01%
YieldMax GOOGL Option Income Stgy ETF
DFUS57.930.95
+1.67%
Dimensional US Equity Market ETF
BJAN45.150.52
+1.17%
Innovator US Equity Buff ETF™ Jan
EMO44.570.32
+0.72%
ClearBridge Energy Midstream Opportunity Fund
FTDS48.410.26
+0.53%
First Trust Dividend Strength ETF

GSGTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSGTF has been loosely correlated with HRTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GSGTF jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSGTF
1D Price
Change %
GSGTF100%
N/A
HRTX - GSGTF
45%
Loosely correlated
+2.33%
RPTX - GSGTF
34%
Loosely correlated
-6.57%
GOSS - GSGTF
30%
Poorly correlated
+7.51%
BVAXF - GSGTF
29%
Poorly correlated
-4.98%
SPRC - GSGTF
29%
Poorly correlated
+4.52%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-6.57%
INO - RPTX
57%
Loosely correlated
+0.81%
BCYC - RPTX
49%
Loosely correlated
-0.69%
CADL - RPTX
39%
Loosely correlated
+0.53%
ALNY - RPTX
38%
Loosely correlated
+2.20%
AXON - RPTX
37%
Loosely correlated
+3.82%
More